- The Board of Directors of Dr. Reddy's Laboratories approved a stock split of each equity share from a face value of Rs. 5 to Rs. 1, making shares more affordable for retail investors.
Unlock the Full Filing And Lot More
Access premium insights and stay ahead of the market with Dzambhala Pro.
Learn MoreDRREDDY PRIOR FILINGS
- 1d ago
- 2d ago
- 13d ago
- 20d ago
- 1mo ago
Dr. Reddy's Laboratories Set to Release Q3FY25 Financial Results on January 23, Earnings Call Sched…
Dr. Reddy's Sells Non-Strategic Subsidiary in USA for USD 1, Contributing ₹320 Cr in Turnover
Dr. Reddy's Laboratories' Bank Facilities Rated ₹2,000 Cr by ICRA with Stable Outlook
Dr. Reddy's Allots 13,080 Equity Shares Under Employees Stock Option Scheme
Dr. Reddy's Ukraine Subsidiary Slapped with EUR 280 Penalty by State Tax Service
ALL LATEST FILINGS
- 15m ago
- 1h ago
- 3h ago
- 12h ago
- 13h ago
Bajaj Auto Faces ₹11.62 Lac Penalty Over Input Tax Credit Discrepancy, Plans To Appeal
NTPC Commences Commercial Operations for 110 MW Solar Capacity in Rajasthan and Madhya Pradesh
JSW Steel Achieves Record Crude Steel Production of 7.03 Million Tonnes in Q3 FY25
Britannia Faces ₹105 Cr GST Tax Demand Over Kulcha Classification Issues
IRB Infrastructure Reports 19% Growth in Toll Revenue to ₹580 Cr for December 2024